10.4103/aja.aja_77_20
Relugolix as a promising novel oral GnRH antagonist for prostate cancer treatment
Jialu Lv1, Jianqing Lin2
1 Ningbo University Medical School, Ningbo 315211, China 2 The George Washington University School of Medicine and Health Sciences, Washington, DC 20037, USA
Correspondence: Dr. J Lin (jilin@mfa.gwu.edu)
24-Nov-2020
|